Huntington Ingalls Industries Inc
Change company Symbol lookup
Select an option...
HII Huntington Ingalls Industries Inc
BABA Alibaba Group Holding Ltd
ABBV Abbvie Inc
OBMP OncBioMune Pharmaceuticals Inc
AVNW Aviat Networks Inc
AMPY Amplify Energy Corp
JEPI JPMorgan Equity Premium Income ETF
VOLAF Volvo AB
AGNC Agnc Investment Corp
GME GameStop Corp
Go

Industrials : Aerospace & Defense | Mid Cap Value
Company profile

Huntington Ingalls Industries, Inc. is a military shipbuilding company and a provider of professional services to partners in government and industry. The Company's business consists of the design, construction, repair and maintenance of nuclear-powered ships and non-nuclear ships for the United States Navy and coastal defense surface ships for the United States Coast Guard, as well as the refueling and overhaul and inactivation of nuclear-powered ships for the United States Navy. It operates through three segments: Ingalls Shipbuilding (Ingalls), Newport News Shipbuilding (Newport News) and Technical Solutions. Its Ingalls segment includes its non-nuclear ship design, construction, repair and maintenance businesses. Its Newport News includes all of its nuclear ship design, construction, overhaul, refueling, and repair and maintenance businesses. Its Technical Solutions segment provides a range of professional services to the governmental and energy markets.

Closing Price
$208.06
Day's Change
-0.29 (-0.14%)
Bid
--
Ask
--
B/A Size
--
Day's High
210.00
Day's Low
206.18
Volume
(Average)
Volume:
274,074

10-day average volume:
303,432
274,074

SHAREHOLDER ALERT: Investigation of Ocugen Announced by Holzer & Holzer, LLC

3:06 pm ET January 25, 2021 (Newsfile) Print

Atlanta, Georgia--(Newsfile Corp. - January 25, 2021) - Holzer & Holzer, LLC is investigating whether Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ: OCGN) complied with federal securities laws. On January 12, 2021, Ocugen announced the cancellation of a Company stockholder meeting for the following day and plans to re-evaluate the details of a proposed increase in the number of shares of common stock "in light of the recent potential addition of COVAXINT to its pipeline as well as its compliance with Nasdaq's Listing Rule 5550(a)(2)." The price of Ocugen's stock fell following the announcement.

If you purchased shares of Ocugen and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at cholzer@holzerlaw.com or Luke R. Kennedy, Esq. at lkennedy@holzerlaw.com, or by toll-free telephone at (888) 508-6832 to discuss your legal rights or at www.holzerlaw.com.

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.

CONTACT:

Corey D. Holzer, Esq.

(888) 508-6832 (toll-free)

cholzer@holzerlaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/72773

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.